Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida speciesĽuboš Drgoňa, Rosemary A. Barnes, Michal Kantecki et al.|European Journal of Clinical Microbiology & Infectious Diseases|2013Cited by 130
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised PatientsRosemary A. Barnes, Johan Maertens, Stephanie Earnshaw et al.|Clinical Therapeutics|2015Cited by 27